{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,2]],"date-time":"2024-06-02T19:35:33Z","timestamp":1717356933847},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,8,30]],"date-time":"2012-08-30T00:00:00Z","timestamp":1346284800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Urban Health"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1007\/s11524-012-9756-9","type":"journal-article","created":{"date-parts":[[2012,8,29]],"date-time":"2012-08-29T16:53:58Z","timestamp":1346259238000},"page":"141-146","source":"Crossref","is-referenced-by-count":4,"title":["Burden of Cervical, Anal, and Oral HPV in an Inner-City Pre-vaccine Adolescent Population"],"prefix":"10.1007","volume":"90","author":[{"given":"Nicolas F.","family":"Schlecht","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary","family":"Rojas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Lorde-Rollins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Nucci-Sack","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Howard D.","family":"Strickler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert D.","family":"Burk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela","family":"Diaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,8,30]]},"reference":[{"issue":"19","key":"9756_CR1","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1056\/NEJMoa061741","volume":"356","author":"FUTURE II","year":"2007","unstructured":"FUTURE II. Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions. N Engl J Med. 2007; 356(19): 1915\u20131927.","journal-title":"N Engl J Med"},{"issue":"9490","key":"9756_CR2","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/S0140-6736(05)67069-9","volume":"366","author":"GM Clifford","year":"2005","unstructured":"Clifford GM, Gallus S, Herrero R, et al. Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis. Lancet. 2005; 366(9490): 991\u2013998.","journal-title":"Lancet"},{"issue":"10","key":"9756_CR3","doi-asserted-by":"crossref","first-page":"696","DOI":"10.4161\/hv.5.10.9515","volume":"5","author":"SE Olsson","year":"2009","unstructured":"Olsson SE, Kjaer SK, Sigurdsson K, et al. Evaluation of quadrivalent HPV 6\/11\/16\/18 vaccine efficacy against cervical and anogenital disease in subjects with serological evidence of prior vaccine type HPV infection. Hum vaccines. 2009; 5(10): 696\u2013704.","journal-title":"Hum vaccines"},{"key":"9756_CR4","unstructured":"Centers for Disease Control and Prevention. National and state vaccination coverage among adolescents aged 13 through 17\u00a0years\u2014United States, 2010. MMWR Morb Mortal Wkly Rep. 2011; 60(33): 1117\u20131123."},{"issue":"3","key":"9756_CR5","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1002\/jmv.10220","volume":"68","author":"PE Castle","year":"2002","unstructured":"Castle PE, Schiffman M, Gravitt PE, et al. Comparisons of HPV DNA detection by MY09\/11 PCR methods. J Med Virol. 2002; 68(3): 417\u2013423.","journal-title":"J Med Virol"},{"issue":"4","key":"9756_CR6","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S1470-2045(09)70096-8","volume":"10","author":"V Bouvard","year":"2009","unstructured":"Bouvard V, Baan R, Straif K, et al. A review of human carcinogens?Part B: biological agents. Lancet Oncol. 2009; 10(4): 321\u2013322.","journal-title":"Lancet Oncol"},{"issue":"3","key":"9756_CR7","first-page":"113","volume":"20","author":"RD Burk","year":"2011","unstructured":"Burk RD, Chen Z, Harari A, et al. Classification and nomenclature system for human Alphapapillomavirus variants: general features, nucleotide landmarks and assignment of HPV6 and HPV11 isolates to variant lineages. Acta derm venereol Alpina Panonica et Adriatica. 2011; 20(3): 113\u2013123.","journal-title":"Acta derm venereol Alpina Panonica et Adriatica"},{"key":"9756_CR8","volume-title":"The design and analysis of clinical experiments","author":"JL Fleiss","year":"1986","unstructured":"Fleiss JL. The design and analysis of clinical experiments. New York: Wiley; 1986."},{"issue":"27\u201328","key":"9756_CR9","doi-asserted-by":"crossref","first-page":"5571","DOI":"10.1016\/j.vaccine.2006.04.068","volume":"24","author":"L Villa","year":"2006","unstructured":"Villa L, Ault K, Giuliano A, et al. Immunologic responses following administration of a vaccine targeting human papillomavirus types 6, 11, 16, and 18. Vaccine. 2006; 24(27\u201328): 5571\u20135583.","journal-title":"Vaccine"},{"issue":"11","key":"9756_CR10","doi-asserted-by":"crossref","first-page":"2632","DOI":"10.1002\/ijc.25940","volume":"129","author":"RM Haupt","year":"2011","unstructured":"Haupt RM, Wheeler CM, Brown DR, et al. Impact of an HPV6\/11\/16\/18\u00a0L1 virus-like particle vaccine on progression to cervical intraepithelial neoplasia in seropositive women with HPV16\/18 infection. Int J Cancer. 2011; 129(11): 2632\u20132642.","journal-title":"Int J Cancer"},{"issue":"19","key":"9756_CR11","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1056\/NEJMoa061760","volume":"356","author":"SM Garland","year":"2007","unstructured":"Garland SM, Hernandez-Avila M, Wheeler CM, et al. Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases. N Engl J Med. 2007; 356(19): 1928\u20131943.","journal-title":"N Engl J Med"},{"issue":"11","key":"9756_CR12","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1016\/j.vaccine.2011.01.001","volume":"29","author":"TJ Kemp","year":"2011","unstructured":"Kemp TJ, Hildesheim A, Safaeian M, et al. HPV16\/18\u00a0L1 VLP vaccine induces cross-neutralizing antibodies that may mediate cross-protection. Vaccine. 2011; 29(11): 2011\u20132014.","journal-title":"Vaccine"},{"issue":"1","key":"9756_CR13","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/S1470-2045(11)70287-X","volume":"13","author":"CM Wheeler","year":"2012","unstructured":"Wheeler CM, Castellsague X, Garland SM, et al. Cross-protective efficacy of HPV-16\/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by non-vaccine oncogenic HPV types: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial. Lancet Oncol. 2012; 13(1): 100\u2013110.","journal-title":"Lancet Oncol"},{"issue":"7","key":"9756_CR14","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1001\/jama.2012.101","volume":"307","author":"ML Gillison","year":"2012","unstructured":"Gillison ML, Broutian T, Pickard RK, et al. Prevalence of oral HPV infection in the United States, 2009\u20132010. JAMA. 2012; 307(7): 693\u2013703.","journal-title":"JAMA"},{"issue":"4","key":"9756_CR15","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1200\/JCO.2007.14.1713","volume":"26","author":"AK Chaturvedi","year":"2008","unstructured":"Chaturvedi AK, Engels EA, Anderson WF, Gillison ML. Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States. J Clin Oncol Off J Am Soc Clin Oncol. 2008; 26(4): 612\u2013619.","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"10","key":"9756_CR16","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1002\/ijc.24215","volume":"124","author":"BE Hoots","year":"2009","unstructured":"Hoots BE, Palefsky JM, Pimenta JM, Smith JS. Human papillomavirus type distribution in anal cancer and anal intraepithelial lesions. Int J Cancer. 2009; 124(10): 2375\u20132383.","journal-title":"Int J Cancer"},{"issue":"5","key":"9756_CR17","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1002\/ijc.26115","volume":"130","author":"A Nielsen","year":"2012","unstructured":"Nielsen A, Munk C, Kjaer SK. Trends in incidence of anal cancer and high-grade anal intraepithelial neoplasia in Denmark, 1978\u20132008. Int J Cancer. 2012; 130(5): 1168\u20131173.","journal-title":"Int J Cancer"},{"issue":"17","key":"9756_CR18","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1056\/NEJMoa1010971","volume":"365","author":"JM Palefsky","year":"2011","unstructured":"Palefsky JM, Giuliano AR, Goldstone S, et al. HPV vaccine against anal HPV infection and anal intraepithelial neoplasia. N Engl J Med. 2011; 365(17): 1576\u20131585.","journal-title":"N Engl J Med"},{"issue":"9","key":"9756_CR19","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/S1470-2045(11)70213-3","volume":"12","author":"AR Kreimer","year":"2011","unstructured":"Kreimer AR, Gonzalez P, Katki HA, et al. Efficacy of a bivalent HPV 16\/18 vaccine against anal HPV 16\/18 infection among young women: a nested analysis within the Costa Rica Vaccine Trial. Lancet Oncol. 2011; 12(9): 862\u2013870.","journal-title":"Lancet Oncol"}],"container-title":["Journal of Urban Health"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11524-012-9756-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11524-012-9756-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11524-012-9756-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T16:19:29Z","timestamp":1559405969000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11524-012-9756-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8,30]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["9756"],"URL":"https:\/\/doi.org\/10.1007\/s11524-012-9756-9","relation":{},"ISSN":["1099-3460","1468-2869"],"issn-type":[{"value":"1099-3460","type":"print"},{"value":"1468-2869","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,8,30]]}}}